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Comparison of Effects of Sleeve Gastrectomy, Duodenal-Jejunal Bypass and 
Ileal Transposition for the Treatment of Type II Diabetes 
Daniel K. Tong, Kenneth K. Lai, Kin-Tak Chan, Nikki P. Lee, Kwan Man, Simon Law 
 
BACKGROUND: Sleeve gastrectomy (SG), duodenal jejunal bypass (DJB) and ileal 
transposition (IT) have been reported to be effective for the treatment of T2DM. It is 
unknown which procedure has a stronger anti-diabetic effect. The purpose of this study 
was to compare the effectiveness of these novel procedures METHODS: SG, DJB, IT 
and sham operation of each procedure were performed in 10-12 weeks old Goto-Kakizaki 
rats, a spontaneous non-obese model of T2DM. The glucose homeostasis effect was 
evaluated by measuring fasting glucose (FBG) and glycosylated haemoglobin (HbA1c). 
Other parameters measured included gut hormonal alteration, body weight and lipid 
profile (cholesterol and triglycerides). RESULTS: All three procedures had significant 
lower FBG when compared to the respective sham groups. DJB and IT had lower FBG 
than SG (SG vs DJB, p=0.023; SG vs IT, p=0.009) whereas DJB and IT had a similar 
FBG level, p=0.678. For HbA1c, all procedures had lower levels than the respective 
sham groups, p<0.001. The HbA1c of SG rebounded on 8th week whereas HbA1c of 
DJB and IT remained at low level. SG had a significant higher HbA1c level than DJB 
and IT, p<0.001 while DJB and IT had a similar level, p=0.685. For gut hormones 
analysis, GLP-1 and GIP levels were raised in DJB. DJB and IT induced more weight 
loss than SG, p=0.045 and p=0.038. DJB and IT significantly lower the cholesterol level 
than their sham groups, p=0.001 and p=0.013. DJB was more effective than SG in 
reducing the cholesterol level, p<0.001. For triglyceride, SG had a lower level, p=0.006, 
DJB had no difference, p=0.663 whereas IT induced a higher level, p=0.012 when 
compared to the respective sham groups. CONCLUSION: SG, DJB and IT all had anti-
diabetic effects. DJB and IT had more potent anti-diabetic effect than SG. Both foregut 
and hindgut theories might explain the anti-diabetic effect in DJB. The lipid absorption 
profile was different in three procedures. Each procedure has different effects on 
metabolic diseases and their clinical application deserve individual consideration. 
